Skip to main content
PMC home page
British Heart Journal logoLink to British Heart Journal
. 1992 Dec;68(6):549–553. doi: 10.1136/hrt.68.12.549

Myocardial dysfunction in patients infected with HIV: prevalence and risk factors

A J Jacob 1, G R Sutherland 1, A G Bird 1, R P Brettle 2, C A Ludlam 1, A McMillan 1, N A Boon 1
PMCID: PMC1025683  PMID: 1334683

Abstract

Objectives—To determine the prevalence of and risk factors for myocardial dysfunction in HIV infection.

Subjects—173 patients infected with HIV underwent echocardiography. 119 were current or previous injection drug users, 38 were homosexuals, 10 were haemophiliac patients, and six were heterosexual.

Main outcome measure—Detection of impaired ventricular function.

Results—26 patients with abnormalities of ventricular size or function or both were identified. The abnormality was (a) dilated cardiomyopathy in 13 patients (eight homosexuals, three drug users, and two haemophiliacs) with a mean CD4 count of 38 cells/mm3, which accords with end-stage disease (in addition, three patients were identified as having borderline impairment of left ventricular function); (b) left ventricular dilatation without loss of function in a further six patients; and (c) isolated right ventricular dilation in seven patients. Follow up echocardiograms were obtained in 71 patients, 18 of whom had myocardial dysfunction (103 echocardiograms, mean (SD) 2·5 (0·6) scans per patient, mean interval 200 (116) days, range 14–538 days). These showed that in four cases of isolated right ventricular dilatation, one of isolated left ventricular dilatation, and two with borderline left ventricular dysfunction myocardial function subsequently reverted to normal. There was no excess of exposure to zidovudine in the patients with myocardial dysfunction. Similarly, patients with myocardial dysfunction had no serological evidence of excess secondary infection with Toxoplasma gondii and cytomegalovirus.

Conclusions—There was a high prevalence and wide range of myocardial dysfunction in HIV positive patients. Dilated cardiomyopathy was a feature of advanced HIV disease and affected all major risk groups for HIV infection. In contrast, isolated dilatation of either ventricle occurred at an earlier stage of HIV infection and, particularly in the case of the right ventricle, often was transient. Neither treatment with zidovudine nor infection with Toxoplasma gondii or cytomegalovirus seemed to be responsible for these findings.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adair O. V., Randive N., Krasnow N. Isolated toxoplasma myocarditis in acquired immune deficiency syndrome. Am Heart J. 1989 Oct;118(4):856–857. doi: 10.1016/0002-8703(89)90607-8. [DOI] [PubMed] [Google Scholar]
  2. Anderson D. W., Virmani R., Reilly J. M., O'Leary T., Cunnion R. E., Robinowitz M., Macher A. M., Punja U., Villaflor S. T., Parrillo J. E. Prevalent myocarditis at necropsy in the acquired immunodeficiency syndrome. J Am Coll Cardiol. 1988 Apr;11(4):792–799. doi: 10.1016/0735-1097(88)90213-6. [DOI] [PubMed] [Google Scholar]
  3. Arnaudo E., Dalakas M., Shanske S., Moraes C. T., DiMauro S., Schon E. A. Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy. Lancet. 1991 Mar 2;337(8740):508–510. doi: 10.1016/0140-6736(91)91294-5. [DOI] [PubMed] [Google Scholar]
  4. Blanchard D. G., Hagenhoff C., Chow L. C., McCann H. A., Dittrich H. C. Reversibility of cardiac abnormalities in human immunodeficiency virus (HIV)-infected individuals: a serial echocardiographic study. J Am Coll Cardiol. 1991 May;17(6):1270–1276. doi: 10.1016/s0735-1097(10)80134-2. [DOI] [PubMed] [Google Scholar]
  5. Calabrese L. H., Proffitt M. R., Yen-Lieberman B., Hobbs R. E., Ratliff N. B. Congestive cardiomyopathy and illness related to the acquired immunodeficiency syndrome (AIDS) associated with isolation of retrovirus from myocardium. Ann Intern Med. 1987 Nov;107(5):691–692. doi: 10.7326/0003-4819-107-5-691. [DOI] [PubMed] [Google Scholar]
  6. Cohen A. J., Weiser B., Afzal Q., Fuhrer J. Ventricular tachycardia in two patients with AIDS receiving ganciclovir (DHPG). AIDS. 1990 Aug;4(8):807–809. doi: 10.1097/00002030-199008000-00014. [DOI] [PubMed] [Google Scholar]
  7. Coplan N. L., Bruno M. S. Acquired immunodeficiency syndrome and heart disease: the present and the future. Am Heart J. 1989 May;117(5):1175–1177. doi: 10.1016/0002-8703(89)90886-7. [DOI] [PubMed] [Google Scholar]
  8. Corallo S., Mutinelli M. R., Moroni M., Lazzarin A., Celano V., Repossini A., Baroldi G. Echocardiography detects myocardial damage in AIDS: prospective study in 102 patients. Eur Heart J. 1988 Aug;9(8):887–892. doi: 10.1093/oxfordjournals.eurheartj.a062583. [DOI] [PubMed] [Google Scholar]
  9. Himelman R. B., Chung W. S., Chernoff D. N., Schiller N. B., Hollander H. Cardiac manifestations of human immunodeficiency virus infection: a two-dimensional echocardiographic study. J Am Coll Cardiol. 1989 Apr;13(5):1030–1036. doi: 10.1016/0735-1097(89)90256-8. [DOI] [PubMed] [Google Scholar]
  10. Himelman R. B., Dohrmann M., Goodman P., Schiller N. B., Starksen N. F., Warnock M., Cheitlin M. D. Severe pulmonary hypertension and cor pulmonale in the acquired immunodeficiency syndrome. Am J Cardiol. 1989 Dec 1;64(19):1396–1399. doi: 10.1016/0002-9149(89)90594-8. [DOI] [PubMed] [Google Scholar]
  11. Ho D. D., Pomerantz R. J., Kaplan J. C. Pathogenesis of infection with human immunodeficiency virus. N Engl J Med. 1987 Jul 30;317(5):278–286. doi: 10.1056/NEJM198707303170505. [DOI] [PubMed] [Google Scholar]
  12. Knoebel S. B. ACC anniversary seminar. Introduction. J Am Coll Cardiol. 1989 Jan;13(1):1–2. doi: 10.1016/0735-1097(89)90539-1. [DOI] [PubMed] [Google Scholar]
  13. Kotler D. P. Malnutrition in HIV infection and AIDS. AIDS. 1989;3 (Suppl 1):S175–S180. doi: 10.1097/00002030-198901001-00025. [DOI] [PubMed] [Google Scholar]
  14. Lipshultz S. E., Chanock S., Sanders S. P., Colan S. D., Perez-Atayde A., McIntosh K. Cardiovascular manifestations of human immunodeficiency virus infection in infants and children. Am J Cardiol. 1989 Jun 15;63(20):1489–1497. doi: 10.1016/0002-9149(89)90014-3. [DOI] [PubMed] [Google Scholar]
  15. Matsuyama T., Kobayashi N., Yamamoto N. Cytokines and HIV infection: is AIDS a tumor necrosis factor disease? AIDS. 1991 Dec;5(12):1405–1417. doi: 10.1097/00002030-199112000-00001. [DOI] [PubMed] [Google Scholar]
  16. Peters B. S., Beck E. J., Coleman D. G., Wadsworth M. J., McGuinness O., Harris J. R., Pinching A. J. Changing disease patterns in patients with AIDS in a referral centre in the United Kingdom: the changing face of AIDS. BMJ. 1991 Jan 26;302(6770):203–207. doi: 10.1136/bmj.302.6770.203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Reilly J. M., Cunnion R. E., Anderson D. W., O'Leary T. J., Simmons J. T., Lane H. C., Fauci A. S., Roberts W. C., Virmani R., Parrillo J. E. Frequency of myocarditis, left ventricular dysfunction and ventricular tachycardia in the acquired immune deficiency syndrome. Am J Cardiol. 1988 Oct 1;62(10 Pt 1):789–793. doi: 10.1016/0002-9149(88)91223-4. [DOI] [PubMed] [Google Scholar]
  18. Richman D. D., Fischl M. A., Grieco M. H., Gottlieb M. S., Volberding P. A., Laskin O. L., Leedom J. M., Groopman J. E., Mildvan D., Hirsch M. S. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med. 1987 Jul 23;317(4):192–197. doi: 10.1056/NEJM198707233170402. [DOI] [PubMed] [Google Scholar]
  19. Wharton J. M., Demopulos P. A., Goldschlager N. Torsade de pointes during administration of pentamidine isethionate. Am J Med. 1987 Sep;83(3):571–576. doi: 10.1016/0002-9343(87)90774-1. [DOI] [PubMed] [Google Scholar]
  20. Zazzo J. F., Chalas J., Lafont A., Camus F., Chappuis P. Is nonobstructive cardiomyopathy in AIDS a selenium deficiency-related disease? JPEN J Parenter Enteral Nutr. 1988 Sep-Oct;12(5):537–538. doi: 10.1177/0148607188012005537. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES